In a high-stakes hearing, a judge will consider whether to order an abortion pill off the market

  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 51%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

A lawsuit filed in Texas challenges the FDA approval of medications used to terminate a pregnancy. The judge has been asked to halt access to one drug nationwide.

do so via medication abortion. If access to mifepristone is halted, those seeking an abortion, and their providers, would have to choose between a surgical procedure or taking the other medication in the regimen, misoprostol, off-label on its own., alleges that the FDA did not adequately evaluate mifepristone’s safety before it approved the drug in 2000, and also argues the agency should not have made the medication accessible via telehealth during the pandemic.

But the Biden administration argues the group doesn’t have the legal standing to bring the lawsuit. That’s one of the issues Kacsmaryk has told the lawyers to prepare to address in the hearing, along with the potential harm of halting access to mifepristone and the implications of implementing such an order nationwide.

There is little legal precedent for a court to overturn a longstanding FDA approval, but abortion providers are nonetheless bracing for the possibility that Kacsmaryk — who was appointed by then-President Donald Trump — will grant the injunction request, since the judge has historically taken conservative stances on abortion rights and other issues.

Erik Baptist, senior counsel at Alliance Defending Freedom, the conservative Christian legal group representing the plaintiffs, said that “the goal of this lawsuit is to protect American women and girls from dangerous chemical abortion drugs.” “We are not seeking a nationwide abortion ban — we’re focusing on one means of abortion here because it’s dangerous, and we are holding the FDA accountable for failing America’s women and girls,” Baptist added.that the FDA reviewed the scientific evidence extensively before approving mifepristone, and that taking it off the market would cause worse health outcomes for people seeking abortions.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 707. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

why is the party always proclaiming that they want the government out of our business... always in our business

Remember... This all could have been avoided if you kept the drag queens away from the children. But nooo. You just HAD to double down thinking we'd, what? Bend the knee? Bow to your rules? Oh no no no sweet babies. Oh no no no.

This doesn't seem right ONE judge can make the determination for this drug for the WHOLE country.

France Dernières Nouvelles, France Actualités